Your contact partner

24 years' experience of global prescription and Over-The-Counter medicines, medical devices, and diagnostics Market Access, Health Technology Appraisal, Pricing and Reimbursement, Strategy, and Competitive Intelligence Management Consultancy; Market Intelligence, Market Research, Medical Education, Regulatory Affairs, and Reimbursement management at UK National Health Service (NHS) Payers makes Consulting for Pharma your expert contact partner.


Simon B Hester


Professional Experience and Education



Simon B Hester has been the Market Access Consultant, Director and Founder of Consulting for Pharma Ltd since May 2012. In addition between 2018 and 2019, Mr Hester was the Global Market Access Manager for Reckitt Benckiser (RB) and was responsible for the Global Market Access, Pricing and Reimbursement, and Health Technology Appraisal Strategies for all the RB Health prescription and Over-The-Counter medicines, medical devices, borderline products, and health products. He has 14 years’ experience in global Pricing and Reimbursement gained in management consultancy, at a major medicines and medical devices manufacturer, and in senior management in health policy and public health at two United Kingdom National Health Service regional Payers responsible for the reimbursement of medicines, medical devices, and diagnostics; 10 years’ experience in global Market Access and Health Technology Appraisal in management consultancy and at a major medicines, medical devices, and health products manufacturer; 2 years’ experience in global Competitive Intelligence management consultancy, and 8 years’ experience in Strategy management consultancy. In total, Mr Hester has 21 years’ experience in the global medicines and medical technology industries gained with a major manufacturer, in competitive and market intelligence; management consultancy, market research, conference and internet content management (medical education); and at the UK Medicines Control Agency (now the Medicines and Healthcare Products Regulatory Agency (MHRA). He has 21 years’ experience in primary research interviewing Payers, Key Opinion Leaders (KOLs), industry Directors, and Hospital Pharmacists gaining Insights and generating Evidence; and 9 years' company strategy, team, project, account/contract, client, business development, financial, vendor, marketing and website management in Market Access management consultancy and for a medicines, medical devices, and diagnostics industry conferences and an internet portal. In addition, Mr Hester has 24 years’ experience in writing business plans and cases, project proposals, value stories, value propositions, dossiers, submissions, literature reviews, reports, presentations, and interview discussion guides; and secondary research information and data research and analysis gaining Insights and generating Evidence.

He has 24 years' experience and knowledge of the global pharmaceutical, biotechnology prescription (Rx) and consumer health (Over-The-Counter, OTC) medicines, medical devices, and diagnostics industries including all Therapeutic Areas (TAs: in particular Cardiovascular, Gastrointestinal, Pulmonary, Oncology, Diabetes, Central Nervous System, Analgesia, Allergy, and Biosimilars); Market Access, Pricing and Reimbursement, Health Technology Appraisal and Assessment, commercialisation, Strategy, R&D, clinical research, drug delivery, marketing, branding, regulatory affairs; Europe, United States, and Canada healthcare Payer policy, systems, and markets, health outcomes, evidence-based medicine, and the United Kingdom National Health Service. Mr Hester has an Master of Philosophy laboratory research degree in Cardiac Muscle Physiology from the University of Liverpool and a Bachelor of Science (Honours) degree in Physiology which includes Clinical Pharmacology, Immunology, and Biochemistry from King’s College London, University of London.



Author of four global, and UK Market Intelligence Reports on global medicine Marketing and Branding Strategies, the UK Pricing and Reimbursement and Health Technology Assessment System for medicines, and Prescription to Over-The-Counter Medicine Switching Strategies; five chapters of a Market Intelligence Report on Western European Pricing and Reimbursement Systems for medicine, and a special feature on the UK success of Over-The-Counter Zocor Heart-Pro (simvastatin) in an Over-The-Counter medicine industry newsletter.


Co-Author of four peer-reviewed, manuscripts and two abstracts on Fife, Scotland General Practitioners’ (primary care physician) views of healthcare services, and Heart Muscle Cell Physiology in General Practice, Cardiology, Pharmacology, and Physiology Journals. Profile


Thought Leadership


Simon has been quoted in several industry newsletters including BioPharm Insight.

Contact and appointments

Please use the contact form for any questions or to make an appointment.